EMERGING PUBLIC BIOTECH

MIMEDX GROUP INC (MDXG)

Marietta, United States · North America
EMERGING PUBLIC BIOTECH
HEADQUARTERS
Marietta, United States
TICKER
MDXG
SEGMENT
Emerging Public Biotech
THERAPY AREAS
KEY PRODUCTS
PRODUCTDETAILS
Bosatria
Trobalt
Potactasol
Nemdatine
Rapilysin
COMPANY OVERVIEW

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the siz…

MIMEDX GROUP INC — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →